
The target comes down, but the love stays
BMO Capital basically said, “We still like the movie, we just don’t think the sequel needs a 10/10 budget.” The firm cut its Fair Isaac price target to $1,700 from $2,200 while keeping an Outperform rating intact.
That matters because FICO has been one of those stocks where the valuation conversation gets louder than the business itself. When analysts trim targets but keep the thumbs-up, they’re usually signaling that the company’s fundamentals are still solid — but the stock has gotten pricey enough that expectations need a reality check.
Why you should care
Even after the downgrade-to-a-less-optimistic-target move, BMO is still above where the shares are trading around $1,046.48, so this isn’t a bear throwing tomatoes. It’s more like a friend saying, “Great dinner, but maybe don’t order dessert for the table.”
For investors, the key question is whether FICO can keep justifying premium multiples in a market that’s getting a little less generous. With the stock already down sharply year to date, the new target can still shape sentiment — especially if more analysts start nudging their numbers lower.
Big picture
No panic here, just a fresher dose of analyst caution. FICO still has believers, but the ceiling is getting lowered — and when a stock is expensive, even small target cuts can feel like a cold splash of water.
